1. Market Research
  2. > Biotechnology Market Trends
  3. > United States Subcutaneous Biologics Industry 2015 Market Research Report

Summary


The United States Subcutaneous Biologics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Subcutaneous Biologics industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Subcutaneous Biologics market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Subcutaneous Biologics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 155 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

United States Subcutaneous Biologics Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Subcutaneous Biologics
1.2 Classification of Subcutaneous Biologics
1.3 Applications of Subcutaneous Biologics
1.4 Industry Chain Structure of Subcutaneous Biologics
1.5 Industry Overview of Subcutaneous Biologics
1.6 Industry Policy Analysis of Subcutaneous Biologics
1.7 Industry News Analysis of Subcutaneous Biologics

2 Manufacturing Cost Structure Analysis of Subcutaneous Biologics
2.1 Bill of Materials (BOM) of Subcutaneous Biologics
2.2 BOM Price Analysis of Subcutaneous Biologics
2.3 Labor Cost Analysis of Subcutaneous Biologics
2.4 Depreciation Cost Analysis of Subcutaneous Biologics
2.5 Manufacturing Cost Structure Analysis of Subcutaneous Biologics
2.6 Manufacturing Process Analysis of Subcutaneous Biologics
2.7 China Price, Cost and Gross of Subcutaneous Biologics 2010-2015

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Subcutaneous Biologics Manufacturers in 2014
3.3 RandD Status and Technology Source of United States Subcutaneous Biologics Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Subcutaneous Biologics Key Manufacturers in 2014

4 Production Analysis of Subcutaneous Biologics by Regions, Type, and Applications
4.1 United States Production of Subcutaneous Biologics by Regions 2010-2015
4.2 United States Production of Subcutaneous Biologics by Type 2010-2015
4.3 United States Sales of Subcutaneous Biologics by Applications 2010-2015
4.4 Price Analysis of United States Subcutaneous Biologics Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Subcutaneous Biologics 2010-2015

5 Consumption Volume and Consumption Value Analysis of Subcutaneous Biologics by Regions
5.1 United States Consumption Volume of Subcutaneous Biologics by Regions 2010-2015
5.2 United States Consumption Value of Subcutaneous Biologics by Regions 2010-2015
5.3 United States Consumption Price Analysis of Subcutaneous Biologics by Regions 2010-2015

6 Analysis of Subcutaneous Biologics Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Subcutaneous Biologics 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Subcutaneous Biologics 2014-2015
6.3 Sales Overview of Subcutaneous Biologics 2010-2015
6.4 Supply, Consumption and Gap of Subcutaneous Biologics 2010-2015
6.5 Import, Export and Consumption of Subcutaneous Biologics 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Subcutaneous Biologics 2010-2015

7 Analysis of Subcutaneous Biologics Industry Key Manufacturers
7.1 Abbott Laboratories
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Abbott Laboratories SWOT Analysis

7.2 Amgen
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Amgen SWOT Analysis

7.3 Baxte
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Baxte SWOT Analysis

7.4 Bayer
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Bayer SWOT Analysis

7.5 Becton Dickinson
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Becton Dickinson SWOT Analysis

7.6 CSL Behring
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 CSL Behring SWOT Analysis

7.7 Eli Lilly
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Eli Lilly SWOT Analysis

7.8 Genzyme
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Genzyme SWOT Analysis

7.9 GSK
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 GSK SWOT Analysis

7.10 Merck
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Merck SWOT Analysis

7.11 Novartis
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Novartis SWOT Analysis

7.12 Novo Nordisk
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Novo Nordisk SWOT Analysis

7.13 Roche
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Roche SWOT Analysis

7.14 Sanofi
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Sanofi SWOT Analysis

7.15 Schott
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Schott SWOT Analysis

7.16 Shandong Weigao
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Shandong Weigao SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Subcutaneous Biologics Product Types
8.5 Market Share Analysis of Different Subcutaneous Biologics Price Levels
8.6 Gross Margin Analysis of Different Subcutaneous Biologics Applications

9 Marketing Trader or Distributor Analysis of Subcutaneous Biologics
9.1 Marketing Channels Status of Subcutaneous Biologics
9.2 Traders or Distributors of Subcutaneous Biologics with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Subcutaneous Biologics
9.4 United States Import, Export and Trade Analysis of Subcutaneous Biologics

10 Development Trend of Subcutaneous Biologics Industry 2016-2021
10.1 Capacity and Production Overview of Subcutaneous Biologics 2016-2021
10.2 Production Market Share by Product Types of Subcutaneous Biologics 2016-2021
10.3 Sales and Sales Revenue Overview of Subcutaneous Biologics 2016-2021
10.4 United States Sales of Subcutaneous Biologics by Applications 2016-2021
10.5 Import, Export and Consumption of Subcutaneous Biologics 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Subcutaneous Biologics 2016-2021

11 Industry Chain Suppliers of Subcutaneous Biologics with Contact Information
11.1 Major Raw Materials Suppliers of Subcutaneous Biologics with Contact Information
11.2 Manufacturing Equipment Suppliers of Subcutaneous Biologics with Contact Information
11.3 Major Players of Subcutaneous Biologics with Contact Information
11.4 Key Consumers of Subcutaneous Biologics with Contact Information
11.5 Supply Chain Relationship Analysis of Subcutaneous Biologics

12 New Project Investment Feasibility Analysis of Subcutaneous Biologics
12.1 New Project SWOT Analysis of Subcutaneous Biologics
12.2 New Project Investment Feasibility Analysis of Subcutaneous Biologics

13 Conclusion of the United States Subcutaneous Biologics Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Subcutaneous Biologics
Table Product Specifications of Subcutaneous Biologics
Table Classification of Subcutaneous Biologics
Figure United States Sales Market Share of Subcutaneous Biologics by Product Types in 2014
Table Applications of Subcutaneous Biologics
Figure United States Sales Market Share of Subcutaneous Biologics by Applications in 2014
Figure Industry Chain Structure of Subcutaneous Biologics
Table United States Industry Overview of Subcutaneous Biologics
Table Industry Policy of Subcutaneous Biologics
Table Industry News List of Subcutaneous Biologics
Table Bill of Materials (BOM) of Subcutaneous Biologics
Table Bill of Materials (BOM) Price of Subcutaneous Biologics
Table Labor Cost of Subcutaneous Biologics
Table Depreciation Cost of Subcutaneous Biologics
Table Manufacturing Cost Structure Analysis of Subcutaneous Biologics in 2014
Figure Manufacturing Process Analysis of Subcutaneous Biologics
Table United States Price Analysis of Subcutaneous Biologics 2010-2015 (USD/Dose)
Table United States Cost Analysis of Subcutaneous Biologics 2010-2015 (USD/Dose)
Table United States Gross Analysis of Subcutaneous Biologics 2010-2015
Table Capacity (Doses) and Commercial Production Date of United States Subcutaneous Biologics Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Subcutaneous Biologics Manufacturers in 2014
Table RandD Status and Technology Source of United States Subcutaneous Biologics Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Subcutaneous Biologics Key Manufacturers in 2014
Table United States Production of Subcutaneous Biologics by Regions 2010-2015 (Doses)
Table United States Production Market Share of Subcutaneous Biologics by Regions 2010-2015
Figure United States Production Market Share of Subcutaneous Biologics by Regions in 2014
Figure United States Production Market Share of Subcutaneous Biologics by Regions in 2015
Table United States Production of Subcutaneous Biologics by Types in 2010-2015 (Doses)
Table United States Production Market Share of Subcutaneous Biologics by Type in 2010-2015
Figure United States Production Market Share of Subcutaneous Biologics by Type in 2014
Figure United States Production Market Share of Subcutaneous Biologics by Type in 2015
Table United States Sales of Subcutaneous Biologics by Applications 2010-2015 (Doses)
Table United States Production Market Share of Subcutaneous Biologics by Applications 2010-2015
Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2014
Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2015
Table Price Comparison of United States Subcutaneous Biologics Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Subcutaneous Biologics 2010-2015
Table United States Consumption Volume of Subcutaneous Biologics by Regions 2010-2015 (Doses)
Table United States Consumption Volume Market Share of Subcutaneous Biologics by Regions 2010-2015 (%)
Figure United States Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2014
Figure United States Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2015
Table United States Consumption Value of Subcutaneous Biologics by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Subcutaneous Biologics by Regions 2010-2015
Figure United States Consumption Value Market Share of Subcutaneous Biologics by Regions in 2014
Figure United States Consumption Value Market Share of Subcutaneous Biologics by Regions in 2015
Table Consumption Price of Subcutaneous Biologics by Regions 2010-2015 (USD/Dose)
Table United States and Major Manufacturers Capacity of Subcutaneous Biologics 2010-2015 (Doses)
Table United States Capacity Market Share of Major Subcutaneous Biologics Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Subcutaneous Biologics 2010-2015 (Doses)
Table United States Production Market Share of Major Subcutaneous Biologics Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Subcutaneous Biologics 2010-2015 (Doses)
Table United States Sales Market Share of Major Subcutaneous Biologics Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Subcutaneous Biologics 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Subcutaneous Biologics Manufacturers 2010-2015
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Subcutaneous Biologics 2010-2015
Figure United States Capacity Utilization Rate of Subcutaneous Biologics 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2010-2015
Figure United States Production Market Share of Major Subcutaneous Biologics Manufacturers in 2014
Figure United States Production Market Share of Major Subcutaneous Biologics Manufacturers in 2015
Figure United States Sales Market Share of Major Subcutaneous Biologics Manufacturers in 2014
Figure United States Sales Market Share of Major Subcutaneous Biologics Manufacturers in 2015
Figure United States Sales (Doses) and Growth Rate of Subcutaneous Biologics 2010-2015
Table United States Supply, Consumption and Gap of Subcutaneous Biologics 2010-2015 (Doses)
Table United States Import, Export and Consumption of Subcutaneous Biologics 2010-2015 (Doses)
Table Price of United States Subcutaneous Biologics Major Manufacturers 2010-2015 (USD/Dose)
Table Gross Margin of United States Subcutaneous Biologics Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Subcutaneous Biologics 2010-2015 (M USD)
Table United States Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2010-2015
Table Abbott Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Abbott Laboratories
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Abbott Laboratories 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Abbott Laboratories 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Abbott Laboratories 2010-2015
Table Abbott Laboratories Subcutaneous Biologics SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Amgen
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Amgen 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Amgen 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Amgen 2010-2015
Table Amgen Subcutaneous Biologics SWOT Analysis
Table Baxte Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Baxte
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Baxte 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Baxte 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Baxte 2010-2015
Table Baxte Subcutaneous Biologics SWOT Analysis
Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Bayer
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bayer 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Bayer 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Bayer 2010-2015
Table Bayer Subcutaneous Biologics SWOT Analysis
Table Becton Dickinson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Becton Dickinson
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Becton Dickinson 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Becton Dickinson 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Becton Dickinson 2010-2015
Table Becton Dickinson Subcutaneous Biologics SWOT Analysis
Table CSL Behring Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of CSL Behring
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of CSL Behring 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of CSL Behring 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of CSL Behring 2010-2015
Table CSL Behring Subcutaneous Biologics SWOT Analysis
Table Eli Lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Eli Lilly
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli Lilly 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Eli Lilly 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Eli Lilly 2010-2015
Table Eli Lilly Subcutaneous Biologics SWOT Analysis
Table Genzyme Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Genzyme
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Genzyme 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Genzyme 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Genzyme 2010-2015
Table Genzyme Subcutaneous Biologics SWOT Analysis
Table GSK Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of GSK
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GSK 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of GSK 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of GSK 2010-2015
Table GSK Subcutaneous Biologics SWOT Analysis
Table Merck Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Merck
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Merck 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Merck 2010-2015
Table Merck Subcutaneous Biologics SWOT Analysis
Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Novartis
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novartis 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Novartis 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Novartis 2010-2015
Table Novartis Subcutaneous Biologics SWOT Analysis
Table Novo Nordisk Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Novo Nordisk
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novo Nordisk 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Novo Nordisk 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Novo Nordisk 2010-2015
Table Novo Nordisk Subcutaneous Biologics SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Roche
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Roche 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Roche 2010-2015
Table Roche Subcutaneous Biologics SWOT Analysis
Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Sanofi
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sanofi 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Sanofi 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Sanofi 2010-2015
Table Sanofi Subcutaneous Biologics SWOT Analysis
Table Schott Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Schott
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Schott 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Schott 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Schott 2010-2015
Table Schott Subcutaneous Biologics SWOT Analysis
Table Shandong Weigao Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Shandong Weigao
Table Subcutaneous Biologics Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Shandong Weigao 2010-2015
Figure Subcutaneous Biologics Capacity (Doses), Production (Doses) and Growth Rate of Shandong Weigao 2010-2015
Figure Subcutaneous Biologics Production (Doses) and United States Market Share of Shandong Weigao 2010-2015
Table Shandong Weigao Subcutaneous Biologics SWOT Analysis
Table Subcutaneous Biologics Price by Regions 2010-2015
Table Subcutaneous Biologics Price by Product Types 2010-2015
Table Subcutaneous Biologics Price by Companies 2010-2015
Table Subcutaneous Biologics Gross Margin by Companies 2010-2015
Table Price Comparison of Subcutaneous Biologics by Regions 2010-2015 (USD/Dose)
Table Price of Different Subcutaneous Biologics Product Types (USD/Dose)
Table Market Share of Different Subcutaneous Biologics Price Level
Table Gross Margin of Different Subcutaneous Biologics Applications
Table Marketing Channels Status of Subcutaneous Biologics
Table Traders or Distributors of Subcutaneous Biologics with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Subcutaneous Biologics (USD/Dose) in 2015
Table United States Import, Export, and Trade of Subcutaneous Biologics (Doses)
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure United States Capacity Utilization Rate of Subcutaneous Biologics 2016-2021
Table United States Subcutaneous Biologics Production by Type 2016-2021 (Doses)
Table United States Subcutaneous Biologics Production Market Share by Type 2016-2021
Figure United States Production Market Share of Subcutaneous Biologics by Type in 2021
Figure United States Sales (Doses) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure United States Sales of Subcutaneous Biologics by Applications 2016-2021 (Doses)
Table United States Production Market Share of Subcutaneous Biologics by Applications 2016-2021
Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2021
Table United States Production, Import, Export and Consumption of Subcutaneous Biologics 2016-2021 (Doses)
Table United States Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2016-2021
Table Major Raw Materials Suppliers of Subcutaneous Biologics with Contact Information
Table Manufacturing Equipment Suppliers of Subcutaneous Biologics with Contact Information
Table Major Players of Subcutaneous Biologics with Contact Information
Table Key Consumers of Subcutaneous Biologics with Contact Information
Table Supply Chain Relationship Analysis of Subcutaneous Biologics
Table New Project SWOT Analysis of Subcutaneous Biologics
Table New Project Investment Feasibility Analysis of Subcutaneous Biologics
Table Part of Interviewees Record List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Bioreactors Market by Scale Range, Material, Usage, Suppliers, End-User, Region - Global Forecast to 2021

Bioreactors Market by Scale Range, Material, Usage, Suppliers, End-User, Region - Global Forecast to 2021

  • $ 18000
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global bioreactors market is expected to reach to USD 1,417 million by 2021 from USD 955 million in 2015, at a CAGR of 6.8% between 2015 and 2021.The increase in adoption of single-use technologies, ...

Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

  • $ 15900
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $24,500.  DataPack (test volumes, sales forecasts, supplier shares) $15,900. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the global cance ...

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.